Levin Arthur A
Director at STOK; Director at Avidity Biosciences, Inc.; Vice President at IONS
- Sold, on record
- $19.2M
- Dollars the filings state
- Form 4 sales
- 35
- Latest Mar 13, 2026
- Form 144 notices
- 9
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- STOKStoke Therapeutics, Inc.Director
- Avidity Biosciences, Inc.Director
- IONSIONIS PHARMACEUTICALS INCVice President
Sales by reason
15
Routine
2
Plan not stated
0
No plan
18
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- Avidity Biosciences, Inc.531,075 shares
- IONS99,194 shares
- STOK13,105 shares
Shares sold, every Form 4 sale on record.
Timeline
- Mar 13, 2026Routine
Sold 12.5% of their holdings
$22k605 shares at $36.80
- Mar 13, 2026Notice
Filed a notice to sell 605 shares
$22k605 shares
- Jan 21, 2026Routine
Sold 9.6% of their holdings
$127k1,758 shares at $72.45
- Aug 6, 2025Unusual
Sold 84.5% of their holdings
$5.1M107,500 shares at $47.62
- Aug 6, 2025Notice
Filed a notice to sell 107,500 shares
$4.1M107,500 shares
- Jan 21, 2025Routine
Sold 12.6% of their holdings
$54k1,872 shares at $28.60
- Nov 19, 2024Routine
Sold 18.3% of their holdings
$140k3,323 shares at $42.12
- Oct 21, 2024Routine
Sold 25.2% of their holdings
$233k5,000 shares at $46.63
- Oct 21, 2024Notice
Filed a notice to sell 8,323 shares
$420k8,323 shares
- Oct 16, 2024Notice
Filed a notice to sell 22,500 shares
$1M22,500 shares
10 of 44
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 5, 2026 | STOK | Director | AwardedDirector Stock Option (Right to Buy) | 17,786 | 17,786 | SEC | ||
| Mar 13, 2026 | Mar 17, 2026 | STOK | Director | Sold | 605 | $36.80 | $22k | 4,237 | SEC |
| Feb 27, 2026 | Feb 27, 2026 | Avidity Biosciences, Inc. | Director | Returned to the companyStock Option (Right to Buy) | 295,523 | 0 | SEC | ||
| Feb 27, 2026 | Feb 27, 2026 | Avidity Biosciences, Inc. | Director | Returned to the company | 147,934 | 0 | SEC | ||
| Jan 21, 2026 | Jan 23, 2026 | Avidity Biosciences, Inc. | Director | Sold | 1,758 | $72.45 | $127k | 16,562 | SEC |
| Dec 31, 2025 | Jan 5, 2026 | STOK | Director | Exercised or settledRestricted Stock Units | 1,211 | 0 | SEC | ||
| Dec 31, 2025 | Jan 5, 2026 | STOK | Director | Exercised options | 1,211 | 4,842 | SEC | ||
| Dec 19, 2025 | Dec 22, 2025 | Avidity Biosciences, Inc. | Director | Gift | 1,330 | 18,320 | SEC | ||
| Sep 30, 2025 | Oct 1, 2025 | STOK | Director | Exercised or settledRestricted Stock Units | 1,211 | 1,211 | SEC | ||
| Sep 30, 2025 | Oct 1, 2025 | STOK | Director | Exercised options | 1,211 | 3,631 | SEC | ||
| Aug 6, 2025 | Aug 8, 2025 | Avidity Biosciences, Inc. | Director | Sold | 107,500 | $47.62 | $5.1M | 19,650 | SEC |
| Aug 6, 2025 | Aug 8, 2025 | Avidity Biosciences, Inc. | Director | Exercised or settledStock Option (Right to Buy) | 107,500 | 12,500 | SEC | ||
| Aug 6, 2025 | Aug 8, 2025 | Avidity Biosciences, Inc. | Director | Exercised options | 107,500 | $22.34 | $2.4M | 127,150 | SEC |
| Jun 30, 2025 | Jul 2, 2025 | STOK | Director | Exercised or settledRestricted Stock Units | 1,210 | 2,422 | SEC | ||
| Jun 30, 2025 | Jul 2, 2025 | STOK | Director | Exercised options | 1,210 | 2,420 | SEC | ||
| Jun 10, 2025 | Jun 12, 2025 | Avidity Biosciences, Inc. | Director | AwardedStock Option (Right to Buy) | 10,034 | 10,034 | SEC | ||
| Jun 10, 2025 | Jun 12, 2025 | Avidity Biosciences, Inc. | Director | Awarded | 6,692 | 19,650 | SEC | ||
| Jun 3, 2025 | Jun 4, 2025 | STOK | Director | AwardedDirector Stock Option (Right to Buy) | 29,747 | 29,747 | SEC | ||
| Mar 31, 2025 | Apr 2, 2025 | STOK | Director | Exercised or settledRestricted Stock Units | 1,210 | 3,632 | SEC | ||
| Mar 31, 2025 | Apr 2, 2025 | STOK | Director | Exercised options | 1,210 | 1,210 | SEC | ||
| Mar 19, 2025 | Mar 20, 2025 | STOK | Director | AwardedRestricted Stock Units | 4,842 | 4,842 | SEC | ||
| Jan 21, 2025 | Jan 23, 2025 | Avidity Biosciences, Inc. | Director | Sold | 1,872 | $28.60 | $54k | 12,958 | SEC |
| Nov 19, 2024 | Nov 20, 2024 | Avidity Biosciences, Inc. | Director | Sold | 3,323 | $42.12 | $140k | 14,830 | SEC |
| Nov 19, 2024 | Nov 20, 2024 | Avidity Biosciences, Inc. | Director | Exercised or settledStock Option (Right to Buy) | 3,323 | 0 | SEC | ||
| Nov 19, 2024 | Nov 20, 2024 | Avidity Biosciences, Inc. | Director | Exercised options | 3,323 | $1.24 | $4k | 18,153 | SEC |
| Oct 21, 2024 | Oct 23, 2024 | Avidity Biosciences, Inc. | Director | Sold | 5,000 | $46.63 | $233k | 14,830 | SEC |
| Oct 21, 2024 | Oct 23, 2024 | Avidity Biosciences, Inc. | Director | Exercised or settledStock Option (Right to Buy) | 5,000 | 3,323 | SEC | ||
| Oct 21, 2024 | Oct 23, 2024 | Avidity Biosciences, Inc. | Director | Exercised options | 5,000 | $1.24 | $6k | 19,830 | SEC |
| Sep 19, 2024 | Sep 20, 2024 | Avidity Biosciences, Inc. | Director | Sold | 5,000 | $45.73 | $229k | 14,830 | SEC |
| Sep 19, 2024 | Sep 20, 2024 | Avidity Biosciences, Inc. | Director | Exercised or settledStock Option (Right to Buy) | 5,000 | 8,323 | SEC | ||
| Sep 19, 2024 | Sep 20, 2024 | Avidity Biosciences, Inc. | Director | Exercised options | 5,000 | $1.24 | $6k | 19,830 | SEC |
| Sep 6, 2024 | Sep 10, 2024 | Avidity Biosciences, Inc. | Director | Gift | 45,000 | 22,500 | SEC | ||
| Aug 19, 2024 | Aug 21, 2024 | Avidity Biosciences, Inc. | Director | Sold | 5,000 | $45.19 | $226k | 14,830 | SEC |
| Aug 19, 2024 | Aug 21, 2024 | Avidity Biosciences, Inc. | Director | Exercised or settledStock Option (Right to Buy) | 5,000 | 13,323 | SEC | ||
| Aug 19, 2024 | Aug 21, 2024 | Avidity Biosciences, Inc. | Director | Exercised options | 5,000 | $1.24 | $6k | 19,830 | SEC |
| Jul 19, 2024 | Jul 23, 2024 | Avidity Biosciences, Inc. | Director | Sold | 5,000 | $45.01 | $225k | 14,830 | SEC |
| Jul 19, 2024 | Jul 23, 2024 | Avidity Biosciences, Inc. | Director | Exercised or settledStock Option (Right to Buy) | 5,000 | 18,323 | SEC | ||
| Jul 19, 2024 | Jul 23, 2024 | Avidity Biosciences, Inc. | Director | Exercised options | 5,000 | $1.24 | $6k | 19,830 | SEC |
| Jun 20, 2024 | Jun 21, 2024 | Avidity Biosciences, Inc. | Director | Sold | 5,000 | $37.59 | $188k | 14,830 | SEC |
| Jun 20, 2024 | Jun 21, 2024 | Avidity Biosciences, Inc. | Director | Exercised or settledStock Option (Right to Buy) | 5,000 | 23,323 | SEC | ||
| Jun 20, 2024 | Jun 21, 2024 | Avidity Biosciences, Inc. | Director | Exercised options | 5,000 | $1.24 | $6k | 19,830 | SEC |
| Jun 13, 2024 | Jun 14, 2024 | Avidity Biosciences, Inc. | Director | Sold | 100,000 | $38.08 | $3.8M | 153,872 | SEC |
| Jun 13, 2024 | Jun 14, 2024 | Avidity Biosciences, Inc. | Director | AwardedStock Option (Right to Buy) | 13,489 | 13,489 | SEC | ||
| Jun 5, 2024 | Jun 7, 2024 | STOK | Director | AwardedDirector Stock Option (Right to Buy) | 7,639 | 7,639 | SEC | ||
| May 20, 2024 | May 21, 2024 | Avidity Biosciences, Inc. | Director | Sold | 5,000 | $29.90 | $150k | 14,830 | SEC |
| May 20, 2024 | May 21, 2024 | Avidity Biosciences, Inc. | Director | Exercised or settledStock Option (Right to Buy) | 5,000 | 28,323 | SEC | ||
| May 20, 2024 | May 21, 2024 | Avidity Biosciences, Inc. | Director | Exercised options | 5,000 | $1.24 | $6k | 19,830 | SEC |
| Apr 19, 2024 | Apr 22, 2024 | Avidity Biosciences, Inc. | Director | Sold | 5,000 | $22.82 | $114k | 14,830 | SEC |
| Apr 19, 2024 | Apr 22, 2024 | Avidity Biosciences, Inc. | Director | Exercised or settledStock Option (Right to Buy) | 5,000 | 33,323 | SEC | ||
| Apr 19, 2024 | Apr 22, 2024 | Avidity Biosciences, Inc. | Director | Exercised options | 5,000 | $1.24 | $6k | 19,830 | SEC |
Page 1
Sales and notices (44)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Mar 17, 2026 | STOK | Director | Form 4 sale | 605 | $22k | 12.5% | Routine | SEC |
| Mar 13, 2026 | Mar 13, 2026 | STOK | Director | Form 144 notice | 605 | $22k | Notice | SEC | |
| Jan 21, 2026 | Jan 23, 2026 | Avidity Biosciences, Inc. | Director | Form 4 sale | 1,758 | $127k | 9.6% | Routine | SEC |
| Aug 6, 2025 | Aug 8, 2025 | Avidity Biosciences, Inc. | Director | Form 4 sale | 107,500 | $5.1M | 84.5% | Unusual | SEC |
| Aug 6, 2025 | Aug 6, 2025 | Avidity Biosciences, Inc. | Director | Form 144 notice | 107,500 | $4.1M | Notice | SEC | |
| Jan 21, 2025 | Jan 23, 2025 | Avidity Biosciences, Inc. | Director | Form 4 sale | 1,872 | $54k | 12.6% | Routine | SEC |
| Nov 19, 2024 | Nov 20, 2024 | Avidity Biosciences, Inc. | Director | Form 4 sale | 3,323 | $140k | 18.3% | Routine | SEC |
| Oct 21, 2024 | Oct 23, 2024 | Avidity Biosciences, Inc. | Director | Form 4 sale | 5,000 | $233k | 25.2% | Routine | SEC |
| Oct 21, 2024 | Oct 21, 2024 | Avidity Biosciences, Inc. | Director | Form 144 notice | 8,323 | $420k | Notice | SEC | |
| Oct 16, 2024 | Oct 16, 2024 | Avidity Biosciences, Inc. | Director | Form 144 notice | 22,500 | $1M | Notice | SEC | |
| Sep 19, 2024 | Sep 20, 2024 | Avidity Biosciences, Inc. | Director | Form 4 sale | 5,000 | $229k | 25.2% | Routine | SEC |
| Aug 19, 2024 | Aug 21, 2024 | Avidity Biosciences, Inc. | Director | Form 4 sale | 5,000 | $226k | 25.2% | Routine | SEC |
| Jul 19, 2024 | Jul 23, 2024 | Avidity Biosciences, Inc. | Director | Form 4 sale | 5,000 | $225k | 25.2% | Routine | SEC |
| Jun 20, 2024 | Jun 21, 2024 | Avidity Biosciences, Inc. | Director | Form 4 sale | 5,000 | $188k | 25.2% | Routine | SEC |
| Jun 20, 2024 | Jun 20, 2024 | Avidity Biosciences, Inc. | Director | Form 144 notice | 20,000 | $767k | Notice | SEC | |
| Jun 13, 2024 | Jun 14, 2024 | Avidity Biosciences, Inc. | Director | Form 4 sale | 100,000 | $3.8M | 39.4% | Unusual | SEC |
| Jun 13, 2024 | Jun 13, 2024 | Avidity Biosciences, Inc. | Director | Form 144 notice | 60,000 | $2.3M | Notice | SEC | |
| Jun 12, 2024 | Jun 12, 2024 | Avidity Biosciences, Inc. | Director | Form 144 notice | 40,000 | $1.2M | Notice | SEC | |
| May 20, 2024 | May 21, 2024 | Avidity Biosciences, Inc. | Director | Form 4 sale | 5,000 | $150k | 25.2% | Routine | SEC |
| Apr 19, 2024 | Apr 22, 2024 | Avidity Biosciences, Inc. | Director | Form 4 sale | 5,000 | $114k | 25.2% | Routine | SEC |
| Apr 3, 2024 | Apr 3, 2024 | Avidity Biosciences, Inc. | Director | Form 4 sale | 20,000 | $542k | 7.3% | Routine | SEC |
| Apr 3, 2024 | Apr 3, 2024 | Avidity Biosciences, Inc. | Director | Form 144 notice | 20,000 | $537k | Notice | SEC | |
| Mar 19, 2024 | Mar 21, 2024 | Avidity Biosciences, Inc. | Director | Form 4 sale | 5,000 | $120k | 25.2% | Routine | SEC |
| Mar 12, 2024 | Mar 12, 2024 | Avidity Biosciences, Inc. | Director | Form 4 sale | 27,641 | $609k | 65.1% | Routine | SEC |
| Mar 12, 2024 | Mar 12, 2024 | Avidity Biosciences, Inc. | Director | Form 144 notice | 42,641 | $896k | Notice | SEC | |
| Jan 22, 2024 | Jan 23, 2024 | Avidity Biosciences, Inc. | Director | Form 4 sale | 1,859 | $19k | 9.6% | Routine | SEC |
| Mar 15, 2023 | Mar 17, 2023 | Avidity Biosciences, Inc. | Director | Form 4 sale | 100 | $2k | 0.5% | Plan not stated | SEC |
| Feb 14, 2023 | Feb 15, 2023 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 10,000 | $237k | 34.1% | Unusual | SEC |
| Jan 12, 2023 | Jan 17, 2023 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 10,000 | $220k | 88.3% | Unusual | SEC |
| Dec 29, 2022 | Jan 3, 2023 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 40,000 | $880k | 96.8% | Unusual | SEC |
| Aug 16, 2022 | Aug 31, 2022 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 80,000 | $1.8M | 98.4% | Unusual | SEC |
| Nov 18, 2021 | Nov 22, 2021 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 25,000 | $697k | 94.9% | Unusual | SEC |
| Jun 25, 2021 | Jun 28, 2021 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 20,200 | $568k | 93.8% | Unusual | SEC |
| Jun 17, 2021 | Jun 22, 2021 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 200 | $6k | 13.1% | Plan not stated | SEC |
| Jun 15, 2021 | Jun 16, 2021 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 37,022 | $962k | 100.0% | Unusual | SEC |
| Mar 16, 2021 | Mar 18, 2021 | Avidity Biosciences, Inc. | Chief Scientific Officer | Form 4 sale | 4,600 | $128k | 100.0% | Unusual | SEC |
| Mar 1, 2021 | Mar 3, 2021 | STOK | Director | Form 4 sale | 12,500 | $760k | 100.0% | Unusual | SEC |
| Apr 25, 2007 | Apr 27, 2007 | IONS | Vice President | Form 4 sale | 6,000 | $61k | 78.2% | Unusual | SEC |
| Nov 13, 2006 | Nov 13, 2006 | IONS | Vice President | Form 4 sale | 50,000 | $603k | 96.8% | Unusual | SEC |
| Oct 19, 2006 | Oct 23, 2006 | IONS | Vice President | Form 4 sale | 12,424 | $112k | 88.1% | Unusual | SEC |
| Oct 6, 2006 | Oct 10, 2006 | IONS | Vice President | Form 4 sale | 10,000 | $80k | 85.7% | Unusual | SEC |
| Mar 21, 2006 | Mar 22, 2006 | IONS | Vice President | Form 4 sale | 10,000 | $90k | 85.7% | Unusual | SEC |
| Feb 17, 2006 | Feb 22, 2006 | IONS | Vice President | Form 4 sale | 7,770 | $62k | 82.3% | Unusual | SEC |
| Feb 16, 2006 | Feb 17, 2006 | IONS | Vice President | Form 4 sale | 3,000 | $24k | 64.2% | Unusual | SEC |